| Dr Kenneth Howard Joel, MD | |
|
3333 Old Milton Pkwy, Alpharetta, GA 30005-4437 | |
| (770) 391-3979 | |
| (770) 391-0020 |
| Full Name | Dr Kenneth Howard Joel |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 44 Years |
| Location | 3333 Old Milton Pkwy, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346236411 | NPI | - | NPPES |
| 000383556C | Medicaid | GA | |
| 000383556B | Medicaid | GA | |
| 000383556D | Medicaid | GA | |
| 000383556F | Medicaid | GA | |
| 000383556G | Medicaid | GA | |
| 000383556E | Medicaid | GA | |
| 050044306 | Other | GA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 027837 (Georgia) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 027837 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pain Physicians Of Atlanta Llc | 4688912934 | 4 |
News Archive
One particular protein is the final executioner of events that result in the death of brain cells during stroke, researchers from UT Southwestern Medical Center and their collaborators report. This finding could ultimately lead to new ways to protect against brain damage.
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.
Top members of the Senate Finance Committee have asked the Obama administration for frequent progress reports on its work to cut down on fraud and abuse in health programs.
› Verified 2 days ago
| Entity Name | North Fulton Anesthesia Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467445262 PECOS PAC ID: 7113914466 Enrollment ID: O20040428000839 |
News Archive
One particular protein is the final executioner of events that result in the death of brain cells during stroke, researchers from UT Southwestern Medical Center and their collaborators report. This finding could ultimately lead to new ways to protect against brain damage.
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.
Top members of the Senate Finance Committee have asked the Obama administration for frequent progress reports on its work to cut down on fraud and abuse in health programs.
› Verified 2 days ago
| Entity Name | Pain Physicians Of Atlanta Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922592641 PECOS PAC ID: 4688912934 Enrollment ID: O20190211003207 |
News Archive
One particular protein is the final executioner of events that result in the death of brain cells during stroke, researchers from UT Southwestern Medical Center and their collaborators report. This finding could ultimately lead to new ways to protect against brain damage.
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.
Top members of the Senate Finance Committee have asked the Obama administration for frequent progress reports on its work to cut down on fraud and abuse in health programs.
› Verified 2 days ago
| Entity Name | Pain Physicians Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194287763 PECOS PAC ID: 8426384736 Enrollment ID: O20190724002940 |
News Archive
One particular protein is the final executioner of events that result in the death of brain cells during stroke, researchers from UT Southwestern Medical Center and their collaborators report. This finding could ultimately lead to new ways to protect against brain damage.
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.
Top members of the Senate Finance Committee have asked the Obama administration for frequent progress reports on its work to cut down on fraud and abuse in health programs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Howard Joel, MD 3333 Old Milton Pkwy Ste 400, Alpharetta, GA 30005-4437 Ph: (770) 391-3979 | Dr Kenneth Howard Joel, MD 3333 Old Milton Pkwy, Alpharetta, GA 30005-4437 Ph: (770) 391-3979 |
News Archive
One particular protein is the final executioner of events that result in the death of brain cells during stroke, researchers from UT Southwestern Medical Center and their collaborators report. This finding could ultimately lead to new ways to protect against brain damage.
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.
Top members of the Senate Finance Committee have asked the Obama administration for frequent progress reports on its work to cut down on fraud and abuse in health programs.
› Verified 2 days ago
Dr. Charisse Nicole Stovall, MD Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 9900 Timberstone Rd, Alpharetta, GA 30022 Phone: 770-864-9107 | |
Dr. Maricela Sanchez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2655 Northwinds Pkwy, Ph5-133 Stern, Alpharetta, GA 30009 Phone: 770-643-5619 | |
Dr. Timothy Griner, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4165 Old Milton Pkwy, Suite 108, Alpharetta, GA 30005 Phone: 770-594-3427 | |
Dr. Ravishanker R Dammanna, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3333 Old Milton Pkwy Ste 400, Alpharetta, GA 30005 Phone: 770-391-3979 Fax: 770-391-0020 | |
Dr. Mohammed Shazad Wada, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3333 Old Milton Pkwy Ste 400, Alpharetta, GA 30005 Phone: 770-391-3979 Fax: 770-391-0020 | |
Kalyani Patel, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 101 Spur Ln, Alpharetta, GA 30009 Phone: 706-339-1437 |